Teriparatide is the only available anabolic drug for treatment of post-menopausal and glucocorticoid-induced osteoporosis. Recent studies demonstrated the efficacy of teriparatide, but few data are available concerning treatment adherence and tolerance. We studied 165 patients treated with teriparatide from 2005 to 2012, with the aim to evaluate long term therapy efficacy, safety and tolerance. Our data demonstrate the efficacy of teriparatide in reducing back pain and preventing new fractures in a large group of patients, and indicate good tolerance and adherence to therapy.
Efficay and safety of teriparatide treatment
LUPO, Sabrina;FRANCESCHETTI, Paola;BONDANELLI, Marta;ZATELLI, Maria Chiara;DEGLI UBERTI, Ettore;AMBROSIO, Maria Rosaria
2013
Abstract
Teriparatide is the only available anabolic drug for treatment of post-menopausal and glucocorticoid-induced osteoporosis. Recent studies demonstrated the efficacy of teriparatide, but few data are available concerning treatment adherence and tolerance. We studied 165 patients treated with teriparatide from 2005 to 2012, with the aim to evaluate long term therapy efficacy, safety and tolerance. Our data demonstrate the efficacy of teriparatide in reducing back pain and preventing new fractures in a large group of patients, and indicate good tolerance and adherence to therapy.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
